Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN-RAY: Daratumumab for SCD Transplant
NCT06358638Phase 2Recruiting
- Sponsor
- Children's National Research Institute
- Start
- Apr 2024
- Primary completion
- Sep 2044
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of daratumumab in sickle cell disease (SCD), sponsored by Children's National Research Institute. Started Apr 2024; status: recruiting.
02
Drugs
daratumumab
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT06358638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06358638.